Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Manfroni

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|April 10, 2015
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) SubunitsSerena Massari, Giulio Nannetti, Jenny Desantis, et al.
European Journal of Medicinal Chemistry|October 2, 2017
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium aviumRolando Cannalire, Diana Machado, Tommaso Felicetti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 30, 2020
C-2 phenyl replacements to obtain potent quinoline-based <i>Staphylococcus aureus</i> NorA inhibitorsTommaso Felicetti, Gianmarco Mangiaterra, Rolando Cannalire, et al.
International Journal of Molecular Sciences|September 29, 2020
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New <i>Staphylococcus aureus</i> NorA InhibitorsRolando Cannalire, Gianmarco Mangiaterra, Tommaso Felicetti, et al.
Chemmedchem|October 24, 2013
Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activityLuca Sancineto, Nunzio Iraci, Serena Massari, et al.
Journal of Medicinal Chemistry|December 10, 2013
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assemblySerena Massari, Giulio Nannetti, Laura Goracci, et al.
Chemmedchem|May 25, 2021
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore SearchNicholas Cedraro, Rolando Cannalire, Andrea Astolfi, et al.
Plos Neglected Tropical Diseases|April 1, 2020
Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: Development of recombinant NS1-based serology and sensitivity to antiviral drugsIlaria Caracciolo, Erick Mora-Cardenas, Chiara Aloise, et al.
European Journal of Medicinal Chemistry|March 25, 2023
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypesTommaso Felicetti, Chin Piaw Gwee, Maria Sole Burali, et al.
European Journal of Medicinal Chemistry|August 13, 2022
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strainsTommaso Felicetti, Nicholas Cedraro, Andrea Astolfi, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|April 10, 2015
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) SubunitsSerena Massari, Giulio Nannetti, Jenny Desantis, et al.
European Journal of Medicinal Chemistry|October 2, 2017
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium aviumRolando Cannalire, Diana Machado, Tommaso Felicetti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 30, 2020
C-2 phenyl replacements to obtain potent quinoline-based <i>Staphylococcus aureus</i> NorA inhibitorsTommaso Felicetti, Gianmarco Mangiaterra, Rolando Cannalire, et al.
International Journal of Molecular Sciences|September 29, 2020
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New <i>Staphylococcus aureus</i> NorA InhibitorsRolando Cannalire, Gianmarco Mangiaterra, Tommaso Felicetti, et al.
Chemmedchem|October 24, 2013
Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activityLuca Sancineto, Nunzio Iraci, Serena Massari, et al.
Journal of Medicinal Chemistry|December 10, 2013
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assemblySerena Massari, Giulio Nannetti, Laura Goracci, et al.
Chemmedchem|May 25, 2021
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore SearchNicholas Cedraro, Rolando Cannalire, Andrea Astolfi, et al.
Plos Neglected Tropical Diseases|April 1, 2020
Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: Development of recombinant NS1-based serology and sensitivity to antiviral drugsIlaria Caracciolo, Erick Mora-Cardenas, Chiara Aloise, et al.
European Journal of Medicinal Chemistry|March 25, 2023
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypesTommaso Felicetti, Chin Piaw Gwee, Maria Sole Burali, et al.
European Journal of Medicinal Chemistry|August 13, 2022
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strainsTommaso Felicetti, Nicholas Cedraro, Andrea Astolfi, et al.
Pageof 9